We are thrilled to announce the grand opening of our Acne Center of Excellence, a pioneering initiative dedicated to advancing the treatment and management of acne for individuals of all ages. At...
Acne Center of Excellence
read more
Information
What's New
Understanding Rosacea: Causes, Triggers, and Treatment Approaches
Rosacea is a chronic skin condition that affects millions worldwide. This condition is characterized by redness, swelling, and acne-like bumps, primarily on the face. If you're living in New York...
Spring 2023 Letter
Madfes Dermatology & Aesthetics Group Spring 2023 letter.
Medical Dermatology
Common Medical Skin Conditions
Cosmetic Treatments
Pre & Post-Treatment Instructions
What's NewSofwave™ Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental and Neck Facial Areas
The U.S. Food and Drug Administration (FDA) approves clearance for lifting the eyebrow and lifting lax submental tissue (beneath the chin) and neck tissue; which can also affect the appearance of lax tissue in the submental neck regions, for subjects aged 22 or older. In addition, the Sofwave system featuring the Company’s proprietary SUPERB TM technology is also cleared by the U.S. FDA for a non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles. – from Sofwave™ News Press Release
- immediate results can be seen as soon as 1 week (ongoing improvements in 3 months after treatment)
- minimal downtime (resume daily activities post treatment!)
- most patients only need one treatment (but may benefit from additional treatments)